|
Hi Gregory, Serina Therapeutics (NYSE: SER) is developing next-generation drug optimization platform technologies with the potential to redefine standards of care across multiple therapeutic areas. Their lead asset, SER-252, targets a large, underserved population living with advanced Parkinson’s disease. Backed by robust clinical validation and a potential streamlined 505(b)(2) regulatory path, SER-252 combines a best-in-class pharmacologic profile with a wearable, non-invasive delivery device. Join our webinar with Serina Therapeutics CEO, Steve Ledger, to hear more about how this company’s pipeline with multiple shots on goal, wide patent moat, and several value inflection points over the next 12-18 months offer a rare opportunity to support an asset with both meaningful patient impact and significant value creation potential.
Serina Therapeutics: Deploying A New Drug Optimization Platform To Take On Parkinson’s Disease Thursday, June 26, 12:00 PM ET / 9:00 AM PT https://forcefamilyoffice.com/events/healthcare/serina-therapeutics-coming-june-26-2025/
Thank you, Elaine Parks
All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.
|